These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

352 related items for PubMed ID: 32365405

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Evaluation of antisense oligonucleotide therapy targeting Hsd17b13 in a fibrosis mice model.
    Ma Y, Cai H, Smith J, Chu CH, Mercer SE, Boehm S, Mcdonald I, Zinker B, Cheng D.
    J Lipid Res; 2024 Mar; 65(3):100514. PubMed ID: 38309418
    [Abstract] [Full Text] [Related]

  • 3. Thrombospondin-I is a critical modulator in non-alcoholic steatohepatitis (NASH).
    Min-DeBartolo J, Schlerman F, Akare S, Wang J, McMahon J, Zhan Y, Syed J, He W, Zhang B, Martinez RV.
    PLoS One; 2019 Mar; 14(12):e0226854. PubMed ID: 31891606
    [Abstract] [Full Text] [Related]

  • 4. The protective effects of Ninjin'yoeito against liver steatosis/fibrosis in a non-alcoholic steatohepatitis model mouse.
    Takano K, Kaneda M, Aoki Y, Fujita N, Chiba S, Michihara S, Han LK, Takahashi R.
    J Nat Med; 2024 Jun; 78(3):514-524. PubMed ID: 38498120
    [Abstract] [Full Text] [Related]

  • 5. The pharmacodynamic and differential gene expression analysis of PPAR α/δ agonist GFT505 in CDAHFD-induced NASH model.
    Liu L, Liu C, Zhao M, Zhang Q, Lu Y, Liu P, Yang H, Yang J, Chen X, Yao Y.
    PLoS One; 2020 Jun; 15(12):e0243911. PubMed ID: 33326461
    [Abstract] [Full Text] [Related]

  • 6. Amelioration of diet-induced steatohepatitis in mice following combined therapy with ASO-Fsp27 and fenofibrate.
    Rajamoorthi A, Arias N, Basta J, Lee RG, Baldán Á.
    J Lipid Res; 2017 Nov; 58(11):2127-2138. PubMed ID: 28874443
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Depletion of hepatic stellate cells inhibits hepatic steatosis in mice.
    Kawahara A, Kanno K, Yonezawa S, Otani Y, Kobayashi T, Tazuma S, Ito M.
    J Gastroenterol Hepatol; 2022 Oct; 37(10):1946-1954. PubMed ID: 35933582
    [Abstract] [Full Text] [Related]

  • 12. Fucoxanthin inhibits hepatic oxidative stress, inflammation, and fibrosis in diet-induced nonalcoholic steatohepatitis model mice.
    Takatani N, Kono Y, Beppu F, Okamatsu-Ogura Y, Yamano Y, Miyashita K, Hosokawa M.
    Biochem Biophys Res Commun; 2020 Jul 23; 528(2):305-310. PubMed ID: 32475638
    [Abstract] [Full Text] [Related]

  • 13. Metabolic and hepatic effects of liraglutide, obeticholic acid and elafibranor in diet-induced obese mouse models of biopsy-confirmed nonalcoholic steatohepatitis.
    Tølbøl KS, Kristiansen MN, Hansen HH, Veidal SS, Rigbolt KT, Gillum MP, Jelsing J, Vrang N, Feigh M.
    World J Gastroenterol; 2018 Jan 14; 24(2):179-194. PubMed ID: 29375204
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Conophylline inhibits high fat diet-induced non-alcoholic fatty liver disease in mice.
    Ohashi T, Nakade Y, Ibusuki M, Kitano R, Yamauchi T, Kimoto S, Inoue T, Kobayashi Y, Sumida Y, Ito K, Nakao H, Umezawa K, Yoneda M.
    PLoS One; 2019 Jan 14; 14(1):e0210068. PubMed ID: 30689650
    [Abstract] [Full Text] [Related]

  • 16. Imaging Fibrogenesis in a Diet-Induced Model of Nonalcoholic Steatohepatitis (NASH).
    Hartimath SV, Boominathan R, Soh V, Cheng P, Deng X, Chong YC, Yong FF, Tan PW, Han W, Robins EG, Goggi JL.
    Contrast Media Mol Imaging; 2019 Jan 14; 2019():6298128. PubMed ID: 31866798
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Liver microRNA-21 is overexpressed in non-alcoholic steatohepatitis and contributes to the disease in experimental models by inhibiting PPARα expression.
    Loyer X, Paradis V, Hénique C, Vion AC, Colnot N, Guerin CL, Devue C, On S, Scetbun J, Romain M, Paul JL, Rothenberg ME, Marcellin P, Durand F, Bedossa P, Prip-Buus C, Baugé E, Staels B, Boulanger CM, Tedgui A, Rautou PE.
    Gut; 2016 Nov 14; 65(11):1882-1894. PubMed ID: 26338827
    [Abstract] [Full Text] [Related]

  • 20. Hepatocellular carcinoma in a mouse model fed a choline-deficient, L-amino acid-defined, high-fat diet.
    Ikawa-Yoshida A, Matsuo S, Kato A, Ohmori Y, Higashida A, Kaneko E, Matsumoto M.
    Int J Exp Pathol; 2017 Aug 14; 98(4):221-233. PubMed ID: 28895242
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.